Although various chemically synthesized materials are essential in medicine, food, and agriculture, they can exert unexpected side effects on the environment and human health by releasing certain toxic chemicals. Therefore, eco-friendly and biocompatible biomaterials based on natural resources are being actively explored. Recently, biosilica derived from diatoms has attracted attention in various biomedical fields, including drug delivery systems (DDS), due to its uniform porous nano-pattern, hierarchical structure, and abundant silanol functional groups. Importantly, the structural characteristics of diatom biosilica improve the solubility of poorly soluble substances and enable sustained release of loaded drugs. Additionally, diatom biosilica predominantly comprises SiO₂, has high biocompatibility, and can easily hybridize with other DDS platforms, including hydrogels and cationic DDS, owing to its strong negative charge and abundant silanol groups. This review explores the potential applications of various diatom biosilica-based DDS in various biomedical fields, with a particular focus on hybrid DDS utilizing them.

Microfluid-derived liposomes (M-Lipo) exhibit great potential as drug and functional substance carriers in pharmaceutical and food science. However, the low liposome membrane stability, attributed to the liquid core, limits their application range. Oleosin, a natural surfactant protein, can improve the stability of the lipid nanoparticle membrane against various environmental stresses, such as heat, drying, and pH change; in addition, it can enable sustained drug release. Here, we proposed the fabrication of oleosin-coated M-Lipo (OM-Lipo) through self-assembly on a microfluidic chip and the evaluation of its anticancer drug (carmustine) delivery efficiency. Nanoparticle characterization revealed that the oleosin coating slightly lowered the membrane potential of M-Lipo and greatly improved their dispersibility. Additionally, the in vitro drug release profile showed that the oleosin coating improved the sustained release of the hydrophobic drug from the phospholipid bilayer in body temperature. Our results suggest that OM-Lipo has sufficient potential in various fields, based on its easy production, excellent stability, and biocompatibility.

Silica-based materials are recognized as effective functional materials across diverse industrial fields, including biomedicine (e.g., drug delivery systems (DDS), biosensors, and tissue engineering), owing to their excellent stability and physicochemical characteristics. Among them, diatom biosilica (DB), which constitutes a major part of aquatic biomass, recently gained significant attention as a valuable biomaterial following breakthroughs in its innovative surface structure, superior biocompatibility and multifunctionality. Therefore, DB is emerging as an alternative to synthetic materials used in the biomedical field. This review comprehensively examines the diverse biological properties of DB, followed by an analysis of harvesting and purification strategies. Then, the current application status of DB in two principal biomedical domains, DDS and biosensors, is evaluated. Furthermore, the convergence of these domains into theragnostic applications addresses a significant unmet clinical need for simultaneous therapeutic intervention and diagnostic monitoring, positioning DB as a transformative biomaterial solution. The unique combination of natural hierarchical architecture, tunable surface properties, and excellent biocompatibility make DB promising candidates for next-generation integrated biomedical platforms to address the growing demand of personalized medicine and precision healthcare solutions.